NCT03946930 · RECRUITING
Cognitive Decline in AD
This is an observational cohort study, not a treatment trial. Researchers are following older adults already diagnosed with Alzheimer's disease to identify which factors, including brain volume on MRI, blood biomarkers like inflammatory markers, physical activity, and insulin signaling, are most strongly linked to faster cognitive decline. The goal is to find targets for future preventive strategies. No phase is specified because no intervention is being tested.
You may qualify if
- Sufficient Cantonese competency for cognitive test
- Clinical diagnosis of AD
- FAST test staging 3-5
You're excluded if
- Subjects who refuse blood taking procedure
- No reliable family caregiver informant (person contact at least once a month)
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-08-21